Rasuvo 12.5 MG per 0.25 ML Auto-Injector
- RxCUI
- 1544386
- RxNorm name
- Rasuvo 12.5 MG per 0.25 ML Auto-Injector
- Display name
- Rasuvo 12.5 MG per 0.25 ML Auto-Injector
- Full name
- Rasuvo 12.5 MG per 0.25 ML Auto-Injector
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:22
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rasuvo | METHOTREXATE | Medexus Pharma Inc. | d0075461-0e7e-4967-9c9b-d6440e912c0e | 2025-12-15 | Boxed warning, Warnings, Adverse reactions | 1544386 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d0075461-0e7e-4967-9c9b-d6440e912c0e | Rasuvo 12.5 MG in 0.25 ML Auto-Injector [PSN] · 0.25 ML methotrexate 50 MG/ML Auto-Injector [Rasuvo] [SBD] · 0.25 ML Rasuvo 50 MG/ML Auto-Injector [SY] · Rasuvo (as methotrexate sodium) 50 MG/ML in 0.25 ML Auto-Injector [SY] · Rasuvo 12.5 MG per 0.25 ML Auto-Injector [SY] | 5 | 10 | These highlights do not include all the information needed to use RASUVO ® safely and effectively. See full prescribing information for RASUVO. RASUVO (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953 | 20251215 |